tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

VERU Stock Latest News

Oppenheimer would be buyers of Veru ahead of January’s top line readout
The FlyOppenheimer would be buyers of Veru ahead of January’s top line readout
2M ago
VERU
Veru announces meta-analysis presentation at ObesityWeek on enobosarm
PremiumThe Fly
Veru announces meta-analysis presentation at ObesityWeek on enobosarm
2M ago
VERU
Veru Ends Sales Agreement with Jefferies, Halts Stock Sales
PremiumCompany Announcements
Veru Ends Sales Agreement with Jefferies, Halts Stock Sales
4M ago
8K
VERU
Veru Inc Reported Earnings. Did it Beat Estimates?
PremiumEarning Releases
Veru Inc Reported Earnings. Did it Beat Estimates?
5M ago
VERU
Veru reports Q3 EPS (7c), consensus (6c)
PremiumThe Fly
Veru reports Q3 EPS (7c), consensus (6c)
5M ago
VERU
VERU Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsVERU Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
VERU
Veru Board Expands with New Independent Director
Premium
Company Announcements
Veru Board Expands with New Independent Director
5M ago
8K
VERU
B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
Premium
The Fly
B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
6M ago
ALT
PFE
Veru announces safety, body composition data from presentations at ADA
PremiumThe Fly
Veru announces safety, body composition data from presentations at ADA
6M ago
VERU
Veru management to meet virtually with B. Riley
PremiumThe Fly
Veru management to meet virtually with B. Riley
6M ago
VERU
Veru announces Heymsfield as Principal Investigator for Phase 2b trial
PremiumThe Fly
Veru announces Heymsfield as Principal Investigator for Phase 2b trial
8M ago
VERU
Veru initiated with a Buy at B. Riley
PremiumThe Fly
Veru initiated with a Buy at B. Riley
8M ago
VERU
Veru Inc Reports Earnings: Did it Beat Estimate Forecasts?
PremiumEarning ReleasesVeru Inc Reports Earnings: Did it Beat Estimate Forecasts?
8M ago
VERU
Veru reports Q2 EPS (7c), consensus (5c)
Premium
The Fly
Veru reports Q2 EPS (7c), consensus (5c)
8M ago
VERU
VERU Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
VERU Upcoming Earnings Report: What to Expect?
8M ago
VERU
Veru price target raised to $3 from $2 at H.C. Wainwright
PremiumThe Fly
Veru price target raised to $3 from $2 at H.C. Wainwright
8M ago
VERU
Veru to present at the GLP-1 Based Therapeutics Summit
PremiumThe Fly
Veru to present at the GLP-1 Based Therapeutics Summit
8M ago
VERU
Veru enrolls first patients in Phase 2b trial of enobosarm, semaglutide
PremiumThe Fly
Veru enrolls first patients in Phase 2b trial of enobosarm, semaglutide
8M ago
VERU
Truist healthcare analyst to hold an analyst/industry conference call
PremiumThe Fly
Truist healthcare analyst to hold an analyst/industry conference call
9M ago
VERU
Truist healthcare analyst to hold an analyst/industry conference call
PremiumThe FlyTruist healthcare analyst to hold an analyst/industry conference call
9M ago
VERU
Veru price target lowered to $5 from $7 at Oppenheimer
Premium
The Fly
Veru price target lowered to $5 from $7 at Oppenheimer
9M ago
VERU
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
9M ago
ANVS
ASTS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >